Qulipta (Atogepant)

Qulipta contains the active drug Atogepant. It is a calcitonin gene-related peptide receptor antagonist used for the preventive treatment of episodic migraine in adults.

Recommended Dosage: The recommended dosage is 10 mg, 30 mg, or 60 mg taken orally (by mouth) once daily with or without food. The maximum recommended daily dose of Qulipta is 60 mg. Swallow pills whole without chewing or crushing. Take Qulipta tablets exactly as your health specialist tell you to take them.

For those with Severe Renal Impairment or End-stage Renal Disease, the proposed dose is 10 mg taken orally once daily.

If you miss/skip a dose of Qulipta (atogepant tablets), try to take it quickly as you remember. But if it’s near/almost time for your next Qulipta dose, skip the missed dose. Take your next dose at about the regularly scheduled time. And do not take an additional dose to make for a skipped/missed dose.

• Do not use Qulipta tablets in patients who are hypersensitive to this medicinal product or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container.
• Qulipta 10mg/30mg/60mg may be responsible for causing fatigue and somnolence in some cases. Patients should avoid performing a skilled task such as driving, and operating machinery) until they are reasonably sure that this medicine does not affect them adversely.
• Since the medicine atogepant is typically metabolized by the liver through oxidation, the use of this medicinal product in those with severe hepatic impairment should be avoided. In such scenarios, a re-challenge is not recommended.
• There is a lack of adequate human findings on the developmental risk related to the use of pills Qulipta 60 mg in pregnant women. This medicine should not be used by pregnant women unless the appropriate benefit to the mother outweighs the possible risk to the fetus.
• As atogepant may be excreted in human milk, precise caution should be exercised when Qulipta is administered to females who are breastfeeding. The possible benefit to the mother should be considered along with the possible risk to the breastfed infant.

What documents are required to import QULIPTA to India?

QULIPTA (atogepant) tablets can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patients Identity Proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from Doctor
• Import permit if applicable

Is QULIPTA available in India?

QULIPTA (atogepant tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• Medicine Price.
• Finding Genuine and reliable sources from Canada, Europe, the USA, and Australia
• Ensuring 100% transparency.

QULIPTA can be made available to patients, doctors, and hospitals in Mumbai, Pune, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of QULIPTA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Qulipta price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

What is the Generic Name for the trade name drug Qulipta®?

Atogepant is the Generic Name for the trade name drug Qulipta®.

What is the Manufacturer Name of Qulipta®?

Qulipta® is manufactured by AbbVie Inc.

Is Qulipta® approved by the FDA?

Yes, Qulipta® is approved by the FDA. Date of first/initial approval: September 28, 2021.

Where can I get Qulipta® tablets at the best price in India?

To get the best Qulipta price in India, kindly contact Indian Pharma Network (a WHO GDP & ISO 9001 : 2008 certified company). For Qulipta®, a valid medical prescription is required from your treating physician. 

How does Qulipta works within the body?

Calcitonin gene-related peptide (CGRP) is a protein in the body and is believed to be a cause of migraine attacks. The protein (CGRP) is believed to play a critical role in migraine attacks by causing pain as well as inflammation.

What is the dosage and form of Qulipta® supplied?

Qulipta® is supplied as Tablets: 10 mg, 30 mg, and 60 mg for oral administration. 

What are the most common side effects of Qulipta®? 

The most common side effects of Qulipta® include: constipation, nausea, and fatigue.

How much does Qulipta® cost in India?

The qulipta cost in India is less and can vary. In order to procure this migraine prevention medication authentically, you can Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Qulipta®?

Store tablets of Qulipta between 15°C to 30°C. Keep the tablets out of the reach and sight of children.

Is it safe to buy Qulipta® tablets online from India?

Yes, you can buy Qulipta tablets online at the best price from the Indian Pharma Network (IPN) if Qelbree has not been approved or is not available in your home country.

What are the Highlights of prescribing information for Qulipta®?

Click Here to download full  Qulipta prescribing information.